Lord, Abbett & Co. LLC Horizon Therapeutics Public LTD CO Transaction History

Lord, Abbett & Co. LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$62.39 - $113.8 $5.14 Million - $9.38 Million	-82,452 Reduced 16.65%	412,677 $47 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $13.8 Million - $19.8 Million	-233,856 Reduced 32.08%	495,129 $30.6 Million
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $20.1 Million - $29.5 Million	253,753 Added 53.4%	728,985 $58.1 Million
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $3.61 Million - $4.59 Million	-41,776 Reduced 8.08%	475,232 $50 Million
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $27.2 Million - $33.1 Million	-276,307 Reduced 34.83%	517,008 $55.7 Million

Q3 2021 Nov 09, 2021	BUY	$91.91 - $110.37 $21.9 Million - $26.4 Million	238,789 Added 43.06%	793,315 $86.9 Million
Q2 2021 Aug 11, 2021	BUY	$86.24 - $95.92 $12.7 Million - $14.1 Million	147,351 Added 36.19%	554,526 $51.9 Million
Q1 2021 May 11, 2021	BUY	$71.83 - $95.48 $26.5 Million - $35.2 Million	368,698 Added 958.23%	407,175 $37.5 Million
Q4 2020 Feb 09, 2021	BUY	$67.0 - $84.39 $1.35 Million - $1.7 Million	20,090 Added 109.26%	38,477 $2.82 Million
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $1.02 Million - $1.47 Million	18,387 New	18,387 $1.43 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.